Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model


Creative Commons License

AKAR E. E., Oner V., Kucukerdonmez C., AKOVA Y. A.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, vol.6, no.2, pp.136-140, 2013 (SCI-Expanded) identifier identifier identifier

Abstract

AIM: To compare the efficacies of subconjunctival bevacizumab, ranibizumab, and pegaptanib sodium injections for the inhibition of corneal neovascularization in an experimental rat model.